Journal
FASEB JOURNAL
Volume 20, Issue 7, Pages 962-+Publisher
FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.05-5538fje
Keywords
TRPM2; cADPR; NAADP
Categories
Funding
- NIAID NIH HHS [R01-AI50200] Funding Source: Medline
- NIGMS NIH HHS [R01-GM 063954, R01-GM 65360] Funding Source: Medline
- NINDS NIH HHS [R01-NS40927] Funding Source: Medline
Ask authors/readers for more resources
TRPM2 (previously designated TRPC7 or LTRPC2) is a Ca(2+)-permeable nonselective cation channel that contains a C-terminal enzymatic domain with pyrophosphatase activity, which specifically binds ADP-ribose. Cyclic ADP-ribose ( cADPR) and hydrogen peroxide (H(2)O(2)) can facilitate ADPR-mediated activation of heterologously expressed TRPM2. Here, we show that the two Ca(2+)-mobilizing second messengers cyclic ADP-ribose ( cADPR) and nicotinic acid adenine dinucleotide phosphate ( NAADP) strongly activate natively expressed TRPM2 channels in Jurkat T cells. TRPM2 activation by both agonists can be partially suppressed by the ADPR antagonist adenosine monophosphate ( AMP), which suggests that cADPR and NAADP lead to mobilization of endogenous ADPR presumably via metabolic conversion. The remaining channel activity is due to direct gating of TRPM2 by the two agonists and can be completely suppressed by 8-Br-cADPR, which suggests that cADPR and NAADP share a common binding site on TRPM2 that can regulate TRPM2 activity in synergy with ADPR. We conclude that cADPR and NAADP, in combination with ADPR, represent physiological co-activators of TRPM2 that contribute to Ca(2+)-influx in T lymphocytes and presumably other cell types that express this channel.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available